The Patent Finder
LP

LB Pharmaceuticals Inc.

First filing 2017
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Seven patents currently held, every record listed here

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Nov 2037. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Nov 2037
Next term end
1
Patent families

When these terms end

Each bar runs from grant to computed term end. 2019 to 2037.
US 10,259,786 Psychotropic Agents and Uses Thereof Nov 28, 2037
US 10,167,256 Psychotropic Agents and Uses Thereof Nov 28, 2037
US 11,040,943 Psychotropic Agents and Uses Thereof Nov 28, 2037
US 10,689,338 Psychotropic Agents and Uses Thereof Nov 28, 2037
US 11,377,421 Psychotropic Agents and Uses Thereof Nov 28, 2037
US 11,713,295 Psychotropic Agents and Uses Thereof Nov 28, 2037
US 12,060,327 Psychotropic Agents and Uses Thereof no later than Nov 28, 2037
201920232027203120352037
A dotted end marks a recorded terminal disclaimer this site has not resolved: the term can only be shorter than the bar, never longer.
2 pending applications: term is not computable until grant.Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 1, 2027
    The maintenance fee for Psychotropic Agents and Uses Thereof (US 11,713,295) comes due Feb 1, 2027. Unpaid by Aug 2, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 7 of 7

PatentTitleStatusExpiresConfidence
US 10,167,256Psychotropic Agents and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 10,259,786Psychotropic Agents and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 10,689,338Psychotropic Agents and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 11,040,943Psychotropic Agents and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 11,377,421Psychotropic Agents and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 11,713,295Psychotropic Agents and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 12,060,327Psychotropic Agents and Uses Thereof
In force
 · Medium confidence
In forceMedium confidence
Also on record, not counted in the 7: 2 applications pending · 2 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
1 terminal disclaimer is on file with no resolved reference. No cap is applied and none is guessed
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited